From: Inhibition of CDK4/6 as a novel therapeutic option for neuroblastoma
Cell line
IC50 (nM)
IMR-32
261
SH-SY5Y
676
NGP
2077
SH-EP
2211
SK-N-SH
7,482 × 105
NLF
1,109 × 104
CLB-GA
2,579 × 105
SK-N-BE(2c)
1,285 × 104